基于二氧化的无药物分层双层膜的选择性瘤抑制效应 通过 响应酸性微环境
Shun Xing1,2, Haifeng Zhang1,2, Lidan Liu1,2
1State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China.
ACS biomaterials science & engineering
|July 5, 2024
概括
研究人员开发了一种对合金支架的酸反应薄膜. 这部电影选择性地向瘤微环境中的癌细胞和细菌,提高治疗的有效性和安全性.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 合金支架对于治疗恶性瘤至关重要,但因瘤入侵和细菌殖民而面临挑战.
- 开发具有向抗癌和抗菌特性的功能化支架对于改善患者的治疗结果至关重要.
- 目前的策略需要改进,以防止恶性阻塞等并发症.
研究的目的:
- 在-合金支架上设计一种对酸反应的层状双氧化物 (LDH) 薄膜.
- 调查电影的选择性癌症抑制和抗菌能力.
- 优化支架在瘤治疗中的治疗潜力.
主要方法:
- 使用热水处理,在合金表面上构建一种对酸有反应的LDH薄膜.
- 在酸性条件下,分析了从LDH膜中释放的离子.
- 使用热处理来调整LDH纳米板表面积和离子释放率.
- 对*S. aureus*和*E. coli*的抗菌活性进行了评估.
- 细胞毒性测试是在正常细胞上进行的.
主要成果:
- 对酸反应的LDH膜有效地诱导了酸性瘤微环境中的癌细胞的氧化应激和细胞死亡.
- 热处理允许调节离子释放,增强抗瘤效果.
- 在LDH薄膜显示显著的抗菌活性对*S. aureus*和*E. coli*.
- 形成的膜在生理条件下对正常细胞具有低毒性.
结论:
- 对酸反应的LDH薄膜为开发功能合金支架提供了一个有希望的策略.
- 这种方法提供了选择性的癌症抑制和抗菌作用,最大限度地减少对健康组织的伤害.
- 这项研究指导了先进支架的设计,以改善干预性瘤治疗.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


